Gallery: How to invest in the driverless car revolution

Set to grow to $96bn by 2025

Laura Dew
clock • 1 min read

Driverless cars are expected to be a huge market for investors, according to Goldman Sachs, which predicts it will grow from $3bn in 2015 to $96bn by 2025.

Driverless cars are expected to be a huge market for investors, according to Goldman Sachs, which predicts it will grow from $3bn in 2015 to $96bn by 2025. Multi-national law firm Gowling WLG asked 1,000 investors which companies in the sector they believes to be the most investible. Stuart Young, partner and head of automotive at Gowling, said: "UK investors have confidence in both the old and new, the big and small. They are tracking the best ideas and conditions whether they come from start-ups or corporate giants."

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

While thematic funds offer diversification and a specialist knowledge base, investors must also consider the sensitivity to real bond yields inherent in these funds.

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
Deal volumes fell last year as rising interest rates brought the end of cheap money

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot